75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
10.1212/wnl.88.16_supplement.p2.165